Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion

CNBC

BusinessCNBC·Sep 2, 2026·1 min read

Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion

Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.

View original source — CNBC ↗

ShareShare on X Share on Facebook

Related stories

Drugmaker Parabilis Raises $745 Million in US IPO, Placement

HealthJun 10, 2026 · 1 min

Drugmaker Parabilis Raises $745 Million in US IPO, Placement

GSK Agrees to Buy Nuvalent for $10.6 Billion

HealthJun 9, 2026 · 1 min

GSK Agrees to Buy Nuvalent for $10.6 Billion

Biotech Kardigan Rises Nearly 2% After $400 Million IPO

HealthJun 18, 2026 · 1 min

Biotech Kardigan Rises Nearly 2% After $400 Million IPO

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Financial Times

HealthJun 9, 2026 · 1 min

GSK in talks to buy cancer biotech Nuvalent for more than $9bn

Financial Times